Bryn Mawr Trust »

Oncocyte Corporation shares owned by Bryn Mawr Trust

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Bryn Mawr Trust from 13F filings

Historical chart of Bryn Mawr Trust investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Bryn Mawr Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $713 250 2.85

More positions owned by Bryn Mawr Trust

Comcast Corp Cl A (CMCSA)
Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Vanguard ETF/USA Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Vanguard Etf/usa Total Stk Mkt (VTI)
Procter & Gamble Company (PG)
iShares ETFs/USA Rus Tp200 Gr Etf (IWY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
SSgA Funds Management Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Core S&p500 Etf (IVV)
iShares ETFs/USA Msci Usa Qlt Fct (QUAL)
BlackRock Fund Advisors Msci Eafe Etf (EFA)

View all positions for Bryn Mawr Trust

Top funds holding Oncocyte Corporation

AWM Investment Company
Vanguard Group
Geode Capital Management
BlackRock
Morgan Stanley
BlackRock
FNY Investment Advisers
State Street Corporation
Northern Trust
Tower Research Capital
Advisor Group Holdings
Bank of America Corporation
Bryn Mawr Trust
Jpmorgan Chase & Co
Piscataqua Savings Bank

View all funds holding Oncocyte Corporation